
Genentech and NVIDIA enter AI research collaboration
Betsy Goodfellow | November 22, 2023 | News story | Research and Development | AI, Genentech, Pharmacy, research collaboration
Genentech has announced that it has entered into a multi-year strategic research collaboration with NVIDIA that is intended to pair Genentech’s artificial intelligence (AI) capabilities, biological and molecular datasets and research expertise with NVIDIA’s accelerated computing capabilities and AI in order to speed up drug discovery and development.
The companies are expected to work together to accelerate and optimise Genentech’s proprietary machine learning (ML) algorithms and models on NVIDIA DGX Cloud software. NVIDIA will share its computing expertise with Genentech’s teams to improve their platforms.
It is intended that this collaboration will provide Genentech’s teams with new insights for target and drug discovery as well as answering fundamental questions about human biology and disease.
Aviv Regev, EVP and head of Genentech Research and Early Development (gRED), commented: “By harnessing the power of AI models and algorithms, with our unique data and experiments, we’re unlocking scientific discoveries with incredible speed and generating insights at an unprecedented scale. Bringing science and technology together has always been a foundation of biomedical breakthroughs at Genentech. We are thrilled to join forces with NVIDIA to further optimise our drug discovery and development to deliver treatments that transform people’s lives.”
Betsy Goodfellow
Related Content

Liverpool launches £20m lab for infectious disease drug discovery
A new £20m high-security laboratory using robotics, artificial intelligence (AI) and human organoids to accelerate …

AI in pharma: From lab development to patient impact
In the decade to 2025, AI use in vaccine development has increased markedly but is …

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set
Bioptimus has partnered with Cancer Research Horizons, the innovation arm of Cancer Research UK, to …





